The VHL–HIF–VEGFR–mTOR pathway, driven by VHL gene inactivation and subsequent HIF accumulation, promotes tumor angiogenesis, cell proliferation, and metastasis in renal cancer. Here, MTOR is linked to renal carcinoma.